These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1330841)

  • 41. Phospholipid metabolism under muscarinic cholinergic stimulation exhibits brain asymmetry.
    Pediconi MF; Barrantes FJ
    Neurochem Res; 1993 May; 18(5):559-64. PubMed ID: 8386336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytidine-5-diphosphocholine supplement in early life induces stable increase in dendritic complexity of neurons in the somatosensory cortex of adult rats.
    Rema V; Bali KK; Ramachandra R; Chugh M; Darokhan Z; Chaudhary R
    Neuroscience; 2008 Aug; 155(2):556-64. PubMed ID: 18619738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphoinositide turnover associated with synaptic transmission.
    Murphy TH; Wright DD; Baraban JM
    J Neurochem; 1992 Dec; 59(6):2336-9. PubMed ID: 1331330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.
    Giménez R; Raïch J; Aguilar J
    Br J Pharmacol; 1991 Nov; 104(3):575-8. PubMed ID: 1839138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.
    Weiss GB
    Life Sci; 1995; 56(9):637-60. PubMed ID: 7869846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of CDP-choline on acetylcholine-induced relaxation of the perfused carotid vascular beds of the rat.
    Pinardi G; Pelissier T; Kramer V; Paeile C; Miranda HF
    Gen Pharmacol; 1994 Jul; 25(4):635-8. PubMed ID: 7958722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of choline with muscarine receptor-stimulated phosphoinositide metabolism in the rat brain.
    Costa LG; Kaylor G; Murphy SD
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):536-9. PubMed ID: 3029607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atropine enhances nicotinic cholinergic EPSPs in rat neostriatal slices.
    Misgeld U; Weiler MH; Cheong DK
    Brain Res; 1982 Dec; 253(1-2):317-20. PubMed ID: 6295554
    [No Abstract]   [Full Text] [Related]  

  • 49. Molecular mechanism underlying the occurrence of supersensitivity at muscarinic receptors: analysis using cerebral cortical neurons in primary culture.
    Kuriyama K; Ohkuma S
    Adv Exp Med Biol; 1991; 287():331-42. PubMed ID: 1759616
    [No Abstract]   [Full Text] [Related]  

  • 50. Repeated calcitonin treatment reduces the stimulation of inositol phospholipid by norepinephrine and serotonin in rat hippocampus and cerebral cortex.
    Clementi G; Favit A; Curreri R; Nicoletti F; Scapagnini U
    Brain Res; 1989 Jan; 478(1):138-42. PubMed ID: 2924109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of acute CDP-choline treatment on resting state brain oscillations in healthy volunteers.
    Knott V; Salle S; Smith D; Choueiry J; Impey D; Smith M; Beaudry E; Saghir S; Ilivitsky V; Labelle A
    Neurosci Lett; 2015 Mar; 591():121-125. PubMed ID: 25700947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NMDA receptor overactivation inhibits phospholipid synthesis by decreasing choline-ethanolamine phosphotransferase activity.
    Gasull T; Sarri E; DeGregorio-Rocasolano N; Trullas R
    J Neurosci; 2003 May; 23(10):4100-7. PubMed ID: 12764097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of receptor-activated phosphoinositide turnover in rat brain: nonequivalence of inositol phosphate and CDP-diacylglycerol formation.
    Heacock AM; Seguin EB; Agranoff BW
    J Neurochem; 1993 Mar; 60(3):1087-92. PubMed ID: 8382261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH-SY-5Y neuroblastoma cells.
    Fisher SK; Slowiejko DM; McEwen EL
    Neurochem Res; 1994 May; 19(5):549-54. PubMed ID: 8065510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of CDP-choline on the biosynthesis of phospholipids in brain regions during hypoxic treatment.
    Alberghina M; Viola M; Serra I; Mistretta A; Giuffrida AM
    J Neurosci Res; 1981; 6(3):421-33. PubMed ID: 7299849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscarinic receptors and the ACh stimulated phosphatidylinositol effect in the CNS.
    Canessa de Scarnati O; Sato M; De Robertis E
    J Neurochem; 1976 Dec; 27(6):1575-7. PubMed ID: 1003235
    [No Abstract]   [Full Text] [Related]  

  • 57. Evidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels.
    López-Coviella I; Agut J; Savci V; Ortiz JA; Wurtman RJ
    J Neurochem; 1995 Aug; 65(2):889-94. PubMed ID: 7616250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake and utilization of CDP-choline in primary brain cell cultures from fetal brain.
    Vecchini A; Binaglia L; Floridi A; Palmerini CA; Procellati G
    Neurochem Res; 1983 Mar; 8(3):333-40. PubMed ID: 6856033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia.
    Kakihana M; Fukuda N; Suno M; Nagaoka A
    Stroke; 1988 Feb; 19(2):217-22. PubMed ID: 3344538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The organization and some projections of cholinergic neurons of the mammalian forebrain.
    Fibiger HC
    Brain Res; 1982 Nov; 257(3):327-88. PubMed ID: 6756546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.